Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
23Andme Holding Co.
(NQ:
ME
)
0.3234
+0.0131 (+4.22%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about 23Andme Holding Co.
< Previous
1
2
3
4
5
6
7
8
9
Next >
Why Tivic Health Systems Are Trading Lower By 55%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
February 09, 2023
Gainers Hempacco Co., Inc. (NASDAQ: HPCO) rose 296% to $2.99 after declining 6% on Wednesday.
Via
Benzinga
MGM Resorts, Madison Square Garden Entertainment, Cardiovascular Systems And Other Big Stocks Moving Higher On Thursday
February 09, 2023
U.S. stocks traded higher, with the Dow Jones gaining around 150 points on Thursday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
A Preview Of 23andMe Holding's Earnings
February 07, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
February 08, 2023
Via
Benzinga
23andMe Reports FY2023 Third Quarter Financial Results
February 08, 2023
From
23andMe Holding Co.
Via
GlobeNewswire
7 Former SPACs I Still Own (And What I Think Now)
January 28, 2023
Remember the SPAC boom? Here are seven products of that time that are still in my portfolio.
Via
The Motley Fool
23andMe to Report FY2023 Third Quarter Financial Results
January 26, 2023
From
23andMe Holding Co.
Via
GlobeNewswire
3 Penny Stocks That Could Make You Filthy Rich
January 25, 2023
These low-priced equities could deliver enormous returns for risk-tolerant shareholders.
Via
The Motley Fool
My 4 Worst-Performing Stocks and What I Think Now
January 10, 2023
These stocks are all down 70% or more from what I paid.
Via
The Motley Fool
Stocks That Hit 52-Week Lows On Friday
January 06, 2023
During Friday's trading, 71 companies set new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
January 05, 2023
On Thursday, 63 companies set new 52-week lows.
Via
Benzinga
Guardant Health, Novavax And Some Other Big Stocks Moving Lower In Today's Pre-Market Session
December 16, 2022
U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today’s pre-market trading session.
Via
Benzinga
25 Meme Stocks to Sell Before They Die
December 15, 2022
Wondering what the best meme stocks to sell for 2023 are? Here are the top picks that investors should offload and avoid.
Via
InvestorPlace
The Worst Investment Decision I Made in 2022
December 10, 2022
The stock market has had a terrible year, and here are some moves we wish we could do over.
Via
The Motley Fool
Why Iovance Biotherapeutics Shares Are Trading Higher By Around 19%? Here Are 40 Stocks Moving In Monday's Mid-Day Session
December 05, 2022
Gainers Winc, Inc. (NYSE: WBEV) rose 88.5% to $0.3901 after dropping over 23% on Friday. Winc, last month, posted a Q3 loss of $0.33 per share.
Via
Benzinga
23andMe Survey Shows Majority of People Less Stressed About Their Health During This Holiday Season
December 01, 2022
From
23andMe Holding Co.
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For November 29, 2022
November 29, 2022
Via
Benzinga
The NIH Has Given BioRestorative Therapies A Stamp Of Approval
November 10, 2022
BioRestorative Therapies Inc. (NASDAQ: BRTX) is working on products that may be solutions to conditions that affect millions of Americans with lower back pain and diabetes.
Via
TheNewswire.com
The NIH Has Given BioRestorative Therapies A Stamp Of Approval
November 09, 2022
BioRestorative Therapies Inc. (NASDAQ: BRTX) is working on products that may be solutions to conditions that affect millions of Americans with lower back pain and diabetes.
Via
Benzinga
23andMe Reports FY2023 Second Quarter Financial Results
November 07, 2022
From
23andMe Holding Co.
Via
GlobeNewswire
23andMe Trials-in-Progress Poster Details Expansion Cohorts for 23ME-00610, an Investigational Antibody Targeting CD200R1, at The Society for Immunotherapy of Cancer’s (SITC) 2022 Annual Meeting
November 07, 2022
The presentation outlines plans for the expansion phase of the study (part B), including the specific tumor indications where 23ME-00610 will be tested for anticancer activity
From
23andMe Holding Co.
Via
GlobeNewswire
A Preview Of 23andMe Holding's Earnings
November 04, 2022
23andMe Holding (NASDAQ:ME) is set to give its latest quarterly earnings report on Monday, 2022-11-07. Here's what investors need to know before the announcement. Analysts estimate that 23andMe Holding...
Via
Benzinga
I Bought 2 SPACs That Haven't Lived Up to Expectations -- Here's Why I'm Still Holding Them
October 28, 2022
These companies haven't performed as well as I thought they would, but I don't plan to sell.
Via
The Motley Fool
23andMe Granted New FDA Clearance to Provide Interpretive Drug Information for a Commonly Prescribed Cholesterol Medication
October 27, 2022
FDA 510(k) clearance allows 23andMe to report genetics associated with processing of certain statins, provides interpretive drug information for simvastatin, and removes the requirement for...
From
23andMe Holding Co.
Via
GlobeNewswire
23andMe to Report FY2023 Second Quarter Financial Results
October 24, 2022
From
23andMe Holding Co.
Via
GlobeNewswire
Bill Gates, Warren Buffett's Initiative For Billionaires To Donate Most Of Their Wealth Sees Sharp Drop In Pledgers In 2022
October 24, 2022
“Giving Pledge” foundation — started by billionaires Bill Gates and Warren Buffett — has seen pledging commitments drop steeply this year, which has been marred by g
Via
Benzinga
2 Budding Growth Stocks That Could Turn $1,000 Into $10,000 in 8 Years
October 21, 2022
They're both using unique and highly efficient approaches to developing and deploying their medicines.
Via
The Motley Fool
23andMe to Present at Upcoming Investor Conferences
October 12, 2022
From
23andMe Holding Co.
Via
GlobeNewswire
23andMe Announces Trials-in-Progress Poster Presentation on 23ME-00610, An Investigational Antibody Targeting CD200R1, at The Society for Immunotherapy of Cancer’s (SITC) 2022 Annual Meeting
October 05, 2022
Poster to provide details on study design and expansion phase for ongoing Phase 1 study in patients with advanced solid malignancies
From
23andMe Holding Co.
Via
GlobeNewswire
7 Undervalued Reddit Stocks to Buy Before Wall Street Catches On
September 28, 2022
Reddit stocks had a bad name once, but over time, Reddit has become a more reliable bellwether for stocks to buy in the short term.
Via
InvestorPlace
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.